Microscopy

The Worldwide Healthcare Machine Vision System Industry is Expected to Reach $4.5 Billion by 2031

Retrieved on: 
Thursday, November 10, 2022

According to this report the healthcare machine vision system market size was valued at $617.40 million in 2021, and is estimated to reach $4.5 billion by 2031, growing at a CAGR of 22.4% from 2022 to 2031.

Key Points: 
  • According to this report the healthcare machine vision system market size was valued at $617.40 million in 2021, and is estimated to reach $4.5 billion by 2031, growing at a CAGR of 22.4% from 2022 to 2031.
  • For the purpose of analysis, the healthcare machine vision system market scope covers segmentation based on product type, type, application, and region.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the healthcare machine vision system market analysis from 2021 to 2031 to identify the prevailing Healthcare machine vision system market opportunities.
  • An in-depth analysis of the healthcare machine vision system market segmentation assists to determine the prevailing market opportunities.

Bruker Announces Acquisition of Inscopix for Neuroscience Research

Retrieved on: 
Tuesday, November 8, 2022

We are very proud of how far Inscopix has come in 10 years, said Dr. Kunal Ghosh, Founder and CEO of Inscopix.

Key Points: 
  • We are very proud of how far Inscopix has come in 10 years, said Dr. Kunal Ghosh, Founder and CEO of Inscopix.
  • Weve built an end-to-end ecosystem for neuroscience research, from reagents and streamlined workflow solutions to a full analysis pipeline.
  • Inscopix has created the head-mounted live-animal microscopy segment as a pioneer in enabling neuroscience research.
  • With over 1000 installations worldwide, these miniscopes are empowering advances in neuroscience research and preclinical research for the development of transformational therapeutics.

Kanazawa University research: The offshoot of cells visualized in real time

Retrieved on: 
Tuesday, November 8, 2022

Small extracellular vesicles (sEVs) are tiny sacs released by cells to deliver chemical messengers to other cells.

Key Points: 
  • Small extracellular vesicles (sEVs) are tiny sacs released by cells to deliver chemical messengers to other cells.
  • A research team led by Richard Wong and Keesiang Lim at Kanazawa University has now used an advanced form of microscopy to elucidate these changes in real time.
  • Thus, research on sEVs for drug development requires a deeper understanding of how stressful environments affect the vesicles' structure.
  • Small extracellular vesicles (sEVs): sEVs are sacs containing chemicals such as proteins, DNA, or metabolites released by cells.

Kanazawa University research: The offshoot of cells visualized in real time

Retrieved on: 
Tuesday, November 8, 2022

Small extracellular vesicles (sEVs) are tiny sacs released by cells to deliver chemical messengers to other cells.

Key Points: 
  • Small extracellular vesicles (sEVs) are tiny sacs released by cells to deliver chemical messengers to other cells.
  • A research team led by Richard Wong and Keesiang Lim at Kanazawa University has now used an advanced form of microscopy to elucidate these changes in real time.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference

Retrieved on: 
Monday, November 7, 2022

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference.
  • A live audio webcast of the question and answer session will be available on the Investor Relations section of the Company's website at https://ir.bruker.com .
  • A replay will be posted in the Events & Presentations section of the Bruker Corporation Investor Relations website after the event and will be available for 90 days.
  • Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.

Keystone Lab Announces In-House Testing for Urine Cultures and Urinalysis

Retrieved on: 
Friday, November 4, 2022

This is possible because referencing out Urine Cultures to another laboratory delays the report by a full day.

Key Points: 
  • This is possible because referencing out Urine Cultures to another laboratory delays the report by a full day.
  • With Keystone bringing the urine cultures in-house, we will expand the testing catalog of reportable antibiotics for gram positive and gram negative bacteria.
  • Please contact Keystone laboratories for the full list of antibiotics that we have expanded our capabilities to in testing.
  • Keystone Laboratories, Inc. is a dual CAP-accredited and CLIA certified lab providing clinical and forensic toxicology testing services for more than 35 years.

Global Healthcare Machine Vision System Market Report to 2031 - Featuring Basler, Cognex, Omron and Sony Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 2, 2022

The "Healthcare Machine Vision System Market By Product Type, By Type, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Healthcare Machine Vision System Market By Product Type, By Type, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
  • For the purpose of analysis, the healthcare machine vision system market scope covers segmentation based on product type, type, application, and region.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the healthcare machine vision system market analysis from 2021 to 2031 to identify the prevailing Healthcare machine vision system market opportunities.
  • An in-depth analysis of the healthcare machine vision system market segmentation assists to determine the prevailing market opportunities.

Penn Dental Medicine Study Finds Cavity-Causing Microbes Form Superorganism that Crawls on Teeth

Retrieved on: 
Tuesday, November 1, 2022

PHILADELPHIA, Nov. 1, 2022 /PRNewswire/ -- A cross-kingdom partnership between bacteria and fungi can result in the two joining to form a "superorganism" with unusual strength and resilience.

Key Points: 
  • PHILADELPHIA, Nov. 1, 2022 /PRNewswire/ -- A cross-kingdom partnership between bacteria and fungi can result in the two joining to form a "superorganism" with unusual strength and resilience.
  • It may sound like science fiction, but these microbial groupings are very much part of the here and now.
  • Found in the saliva of toddlers with severe childhood tooth decay, these assemblages can effectively colonize teeth.
  • They were stickier, more resistant to antimicrobials, and more difficult to remove from teeth than either the bacteria or the fungi alone, according to a research team led by University of Pennsylvania School of Dental Medicine scientists.

New PI Nano Focusing & Positioning Stages for Imaging and Super Resolution Microscopy @ Neuroscience 2022

Retrieved on: 
Tuesday, November 1, 2022

SAN DIEGO, Nov. 1, 2022 /PRNewswire-PRWeb/ -- Biologists, and Neuroscientists and Microscopy Specialists from around the world are gathering in San Diego to share their research, new ideas, and experience the best their field has to offer. PI engineers are on-hand to answer questions and discuss nanopositioning solutions relating to life-science and microscopy projects in industry and research.

Key Points: 
  • PI engineers are on-hand to answer questions and discuss nanopositioning solutions relating to life-science and microscopy projects in industry and research.
  • PI is well-known for its piezo-based high-speed nanopositioning and scanning systems designed to improve super-resolution microscopy results.
  • Researchers make use of the sub-atomic resolution and extreme responsiveness of piezo stages and nanopositioners to create higher-quality images faster.
  • PI provides a large variety of fast Z-sample stages and XYZ nanopositioning and scanning for 3D imaging, deconvolution, and fast auto-focusing applications.

Vivid Microscopy's technology detects stages of cardiac microvascular disease using an animal-based model as demonstrated in a University of Louisville study

Retrieved on: 
Wednesday, October 26, 2022

WAUWATOSA, Wis., Oct. 26, 2022 /PRNewswire/ -- Vivid Microscopy, an emerging biotech company in the United States, today announced the successful use of its high content screening probe, SEMKUR-IM, in a study conducted by the University of Louisville on coronary microvascular disease (CMD) in post-menopausal women. 

Key Points: 
  • A disease impacting over 3 million women yearly, microvascular dysfunction often presents with chest pain and shortness of breath, which can lead to heart failure.
  • Early detection of the microvascular dysregulation signal is criticalif left undetected, it can lead to heart failure or a massive heart attack.
  • The University of Louisville's study has demonstrated how Vivid's probe can be used to ascertain the effectiveness of new cardiovascular treatments.
  • Using fluorescent technology to detect biomarkers associated with cellular injury, Vivid Microscopy has manufactured SEMKUR-IM, a quantitative test to evaluate cellular damage.